Cite Filings / ALDX / 0001564590-21-018848

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Aldeyra Therapeutics, Inc. Filed 2021-04-14 Acc 0001564590-21-018848

Documents 1

DEFA14A Proxy Materials , aldx-defa14a_20210608.htm

Around this filing

2022-04-25 DEFA14A Proxy Materials
2021-04-14 DEFA14A Proxy Materials
2021-04-14 DEF 14A Proxy Statement
2021-04-14 4 Options or other derivatives
2021-04-14 4 Options or other derivatives
2021-04-14 4 President and CEO acquired 46,619 shares (grant or award)
2020-04-27 DEFA14A Proxy Materials

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading aldx-defa14a_20210608.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…